Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA

BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic caused by infection with severe acute respiratory syndrome – coronavirus-2 (SARS-CoV-2) continues to affect many countries and large populations. Serologic assays for antibody detection aid patient diagnosis and seroepidemiologic investigation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Ruta, Patil, Harshad P., Palkar, Sonali, Lalwani, Sanjay, Mishra, Akhilesh Chandra, Arankalle, Vidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581401/
https://www.ncbi.nlm.nih.gov/pubmed/33126149
http://dx.doi.org/10.1016/j.jviromet.2020.113996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581401/
https://www.ncbi.nlm.nih.gov/pubmed/33126149
http://dx.doi.org/10.1016/j.jviromet.2020.113996

Ejemplares similares